Weiss Asset Management LP

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1357550 BOSTON, MA

Position in ESPR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$0

New position

Shares Held

847,118

first reported quarter

Ownership

0.329%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Weiss Asset Management LP holds $2,334,832 across 5 Drug Manufacturers - Specialty & Generic names. ESPR ranks #5 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	2,281	$1,235,914
2	ALKS	Alkermes plc.	9,970	$522,428
3	XERS	Xeris Biopharma Holdings, Inc.	36,488	$288,984
4	LQDA	Liquidia Corp	3,606	$287,506
5	ESPR	Esperion Therapeutics, Inc. This page	847,118	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	847,118	—	Shares	Defined	2026-08-14
No filing history on record for this holder in this stock.